跳至主要内容
临床试验/NCT05108987
NCT05108987已完成不适用

Exercise Time of Day for Cardiometabolic Health in Type 2 Diabetes

Rutgers, The State University of New Jersey6 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2021年9月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
6
主要终点
Body Weight

研究概览

简要总结

The overall purpose of the study is to test the effect exercise time of day in adults with type 2 diabetes or prediabetes. The overarching hypothesis is that afternoon exercise in the afternoon may promote better changes in metabolic and vascular insulin sensitivity. We anticipate that these changes will correlate with glycemic control and blood pressure changes.

详细描述

Type 2 diabetes (T2D) is associated with a 3-fold cardiovascular disease (CVD) mortality risk compared with healthy controls, and it is estimated that 30 million adults in the United States have the disease. In recent years the American Diabetes Association (ADA) and American College of Sports Medicine (ACSM) recommend moderate intensity (40-60% heart rate max, HRmax) aerobic exercise 3-5d/wk for the management of T2D. The statement also recognized that higher exercise intensity (>60% HRmax) predicts better blood glucose control than exercise volume. Cardiovascular health (e.g. fitness, blood pressure, etc.) also appears to respond in an exercise dose dependent manner. Despite these suggestions, many people exercising compensate by eating calories back from exercise, thereby negating weight loss. Moreover, compliance and adherence to exercise and diet medical counsel is disappointingly low.

Recent work has begun to target the best time of day to exercise in effort to improve weight loss and related health. This has evolved in part since circadian biology reveals people tend to become glucose intolerant, and develop insulin resistance and endothelial dysfunction in the evening compared with morning. As a result, it would be reasonable to hypothesize that exercise in the afternoon may be best at combating natural declines in health as well as optimizing training adaptations. However, not all studies agree that afternoon is the best time to exercise. In fact, some have demonstrated that 12 wks of aerobic plus resistance exercise improved glycemic control whether performed in the morning or afternoon in adults with T2D. Moreover, consistent morning exercise has been suggested to improve exercise adherence through possible enjoyment as well as lead to greater weight loss. Taken together, additional work is warranted to understand time of day in which exercise is performed given circadian influence may contribute to variations in favorable metabolic as well as vascular adaptation for CVD prevention/treatment. Excitingly, we have preliminary data showing that afternoon exercise induces greater weight loss, reductions in food intake as well as perceptions of appetite and increased insulin sensitivity when compared to morning exercisers. Thus, the overall purpose of this proposal is to determine whether exercise time of day differentially enhances likelihood of weight loss via appetite regulation as well as glycemic control. Our overarching hypothesis is that afternoon exercise will enhance the effectiveness of exercise to induce weight loss, improve appetite and improve glycemic regulation compared to exercise in the morning. Taken together, findings from this study will inform public health recommendations to contemporary behavioral strategies to treat T2D. The study will also provide much needed experimental evidence to time of day in which exercise is performed influences public health risk.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female >30 and <80 years old.
  • Has a body mass index >25 and <45 kg/m
  • Previously diagnosed with prediabetes and/or T2D.
  • If not previously diagnosed, has a fasting blood glucose ≥ 100 mg/dL and/or HbA1c ≥ 5.7%

排除标准

  • Morbidly obese patients (BMI >45 kg/m2) and lean patients (BMI <25 kg/m2)
  • Evidence of type 1 diabetes and diabetics requiring insulin therapy.
  • Subjects who have not been weight stable (>2 kg weight change in past 3 months)
  • Subjects who have been recently active (>30 min of moderate/high intensity exercise, 3 times/week).
  • Subjects who are smokers or who have quit smoking <1 years ago
  • Subjects with abnormal estimated glomerular filtration rate (eGFR).
  • Hypertriglyceridemic (>400 mg/dl) and hypercholesterolemic (>260 mg/dl) subjects
  • Hypertensive (>160/100 mmHg)
  • Subjects with a history of significant metabolic, cardiac, congestive heart failure, cerebrovascular, hematological, pulmonary, gastrointestinal, liver, renal, or endocrine disease or cancer that in the investigator's opinion would interfere with, alter the outcome measures, or impact subject safety.
  • Pregnant (as evidenced by positive urine pregnancy test) or nursing women.
  • Subjects with contraindications to participation in an exercise training program
  • Currently taking active weight suppression medication (e.g. phentermine,orlistat, lorcaserin, naltrexone-bupropion in combination, liraglutide, benzphetamine, diethylpropion, phendimetrazine)
  • Known hypersensitivity to perflutren (contained in Definity)

研究组 & 干预措施

Morning Exercise

Experimental

If participants are randomly assigned to this group, they will participate in exercise training in the morning (between 7:00am - 11:00am) at an exercise intensity ~85% VO2max. Participants will be asked to regularly engage in morning exercise while supervised for about 2 weeks.

干预措施: Morning Exercise (Behavioral)

Afternoon Exercise

Active Comparator

If participants are randomly assigned to this group, they will participate in exercise training in the afternoon (between 4:00pm - 8:00pm) at an exercise intensity ~85% VO2max. Participants will be asked to regularly engage in afternoon exercise while supervised for about 2 weeks.

干预措施: Afternoon Exercise (Behavioral)

结局指标

主要结局

Body Weight

时间窗: Over the course of 2 weeks.

The primary outcome is changes in body weight pre- and post-intervention

次要结局

  • Glucose Tolerance(Over the course of 2 weeks.)
  • Flow-mediated dilation(Over the course of 2 weeks.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steven K Malin, PhD

Professor

Rutgers, The State University of New Jersey

研究点 (6)

Loading locations...

相似试验